The Fusion Protein market is a subset of the Drug Discovery market, focusing on the development of fusion proteins for therapeutic use. Fusion proteins are created by combining two or more proteins, which can be used to increase the stability, solubility, and bioavailability of the proteins. Fusion proteins can also be used to target specific tissues or organs, or to increase the half-life of a protein. Fusion proteins are used in a variety of therapeutic areas, including oncology, immunology, and metabolic diseases. They are also used in the development of vaccines and diagnostics. Companies in the Fusion Protein market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
